These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11133911)

  • 21. Characterization of exosurf (surfactant)-mediated suppression of stimulated human alveolar macrophage cytokine responses.
    Thomassen MJ; Antal JM; Connors MJ; Meeker DP; Wiedemann HP
    Am J Respir Cell Mol Biol; 1994 Apr; 10(4):399-404. PubMed ID: 8136155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exogenous surfactants in a piglet model of acute respiratory distress syndrome.
    Sood SL; Balaraman V; Finn KC; Britton B; Uyehara CF; Easa D
    Am J Respir Crit Care Med; 1996 Feb; 153(2):820-8. PubMed ID: 8564138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunosuppressive properties of surfactant in alveolar macrophage NR8383.
    Kerecman J; Mustafa SB; Vasquez MM; Dixon PS; Castro R
    Inflamm Res; 2008 Mar; 57(3):118-25. PubMed ID: 18369576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bulk shear viscosities of endogenous and exogenous lung surfactants.
    King DM; Wang Z; Palmer HJ; Holm BA; Notter RH
    Am J Physiol Lung Cell Mol Physiol; 2002 Feb; 282(2):L277-84. PubMed ID: 11792632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants.
    Hall SB; Venkitaraman AR; Whitsett JA; Holm BA; Notter RH
    Am Rev Respir Dis; 1992 Jan; 145(1):24-30. PubMed ID: 1731593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative efficacy of exosurf and survanta surfactants on early clinical course of respiratory distress syndrome and complications of prematurity.
    Modanlou HD; Beharry K; Padilla G; Norris K; Safvati S; Aranda JV
    J Perinatol; 1997; 17(6):455-60. PubMed ID: 9447532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of modified natural or synthetic surfactant preparations on growth of bacteria causing infections in the neonatal period.
    Rauprich P; Möller O; Walter G; Herting E; Robertson B
    Clin Diagn Lab Immunol; 2000 Sep; 7(5):817-22. PubMed ID: 10973461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperoxia effects on pulmonary pressure: volume characteristics and lavage surfactant phospholipid in the newborn rabbit.
    Ward JA; Roberts RJ
    Biol Neonate; 1984; 46(3):139-48. PubMed ID: 6547862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exogenous surfactant decreases oxygenation in Escherichia coli endotoxin-treated neonatal piglets.
    Sood SL; Balaraman V; Finn KC; Wilkerson SY; Mundie TG; Easa D
    Pediatr Pulmonol; 1996 Dec; 22(6):376-86. PubMed ID: 9016471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of surfactant mixtures with reactive oxygen and nitrogen species.
    Cifuentes J; Ruiz-Oronoz J; Myles C; Nieves B; Carlo WA; Matalon S
    J Appl Physiol (1985); 1995 May; 78(5):1800-5. PubMed ID: 7649915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phospholipid Composition in Synthetic Surfactants Is Important for Tidal Volumes and Alveolar Stability in Surfactant-Treated Preterm Newborn Rabbits.
    Calkovska A; Linderholm B; Haegerstrand-Björkman M; Pioselli B; Pelizzi N; Johansson J; Curstedt T
    Neonatology; 2016; 109(3):177-85. PubMed ID: 26757268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between alveolar saturated phosphatidylcholine pool sizes and compliance of preterm rabbit lungs. The effect of maternal corticosteroid treatment.
    Ikegami M; Jobe AH; Yamada T; Seidner S
    Am Rev Respir Dis; 1989 Feb; 139(2):367-9. PubMed ID: 2913885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The physiologic effects of surfactant treatment on gas exchange in newborn premature infants with hyaline membrane disease.
    Cotton RB; Olsson T; Law AB; Parker RA; Lindstrom DP; Silberberg AR; Sundell HW; Sandberg K
    Pediatr Res; 1993 Oct; 34(4):495-501. PubMed ID: 8255684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postnatal transformations of alveolar surfactant in the rabbit: changes in pool size, pool morphology and isoforms of the 32-38 kDa apolipoprotein.
    Bruni R; Baritussio A; Quaglino D; Gabelli C; Benevento M; Ronchetti IP
    Biochim Biophys Acta; 1988 Feb; 958(2):255-67. PubMed ID: 3337839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of exogenous pulmonary surfactants on mortality rate in neonatal respiratory distress syndrome: A network meta-analysis of randomized controlled trials.
    Zhang L; Cao HY; Zhao S; Yuan LJ; Han D; Jiang H; Wu S; Wu HM
    Pulm Pharmacol Ther; 2015 Oct; 34():46-54. PubMed ID: 26296793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exosurf versus Survanta surfactant preparations: proportional-hazards regression analysis of time to successful extubation and discontinuation of oxygen therapy.
    Arnold C; Adams E; Torres E; Sidebottom R
    J Perinatol; 1996; 16(1):9-14. PubMed ID: 8869533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeated doses of the perfluorocarbon FC-100 improve lung function of preterm lambs.
    Moya FR; Llanos AJ; Ríos AM; Riquelme RA; Moraga FA; Rubio LA; Salvo HD; Jacobs HC
    Pediatr Res; 1997 Dec; 42(6):893-8. PubMed ID: 9396575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of three surfactant preparations on in vitro lymphocyte functions.
    Woerndle S; Bartmann P
    J Perinat Med; 1994; 22(2):119-28. PubMed ID: 7965541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biophysical models in investigations of exogenous surfactant activities on the surface tension and their theurapeutic effectiveness].
    Todorov R; Iordanova A; Georgiev GA; Petkova Kh; Stoimenova E; Georgieva R; Khristova E; Vasiliev Kh; Lalchev Z
    Akush Ginekol (Sofiia); 2007; 46 Suppl 1():29-36. PubMed ID: 18175392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of in vitro surface properties of clove oil-phospholipid suspensions with those of ALEC, Exosurf and Survanta.
    Banerjee R; Bellare JR
    Pulm Pharmacol Ther; 2001; 14(2):85-91. PubMed ID: 11273788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.